ErbB-1 (also known as EGFR, epidermal growth factor receptor) and ErbB-2 (also known as HER2, human epidermal growth factor receptor 2), are famous therapeutic targets for cancer treatment and their excessive signaling play critical roles in the development and malignancy of many tumors. Here, ERBB2 is linked to cancer.